Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research

Mark E. Polhemus, Alan J. Magill, James F. Cummings, Kent E. Kester, Chris Ockenhouse, David E. Lanar, Sheetij Dutta, Arnoldo Barbosa, Lorraine Soisson, Carter L. Diggs,

Vaccine · 2007 · 100 citations · 31 references

Concepts

References

31